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Abstract 
This article discusses the use of nanotechnology for subcellular compartment isolation and its application towards 
subcellular omics. This technology review significantly contributes to our understanding on use of nanotechnology 
for subcellular systems biology. Here we elaborate nanobiotechnology approach of using superparamagnetic nano-
particles (SPMNPs) optimized with different surface coatings for subcellular organelle isolation. Using pulse-chase 
approach, we review that SPMNPs interacted differently with the cell depending on its surface functionalization. The 
article focuses on the use of functionalized-SPMNPs as a nanobiotechnology tool to isolate high quality (both purity 
and yield) plasma membranes and endosomes or lysosomes. Such nanobiotechnology tool can be applied in gen-
erating subcellular compartment inventories. As a future perspective, this strategy could be applied in areas such as 
immunology, cancer and stem cell research.
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1  Background
Nanotechnology is defined as molecular engineering of 
functional systems for generating high performance tech-
nologies for both research and industry [1, 2]. Specifi-
cally, use of molecular engineering of biological systems 
resulted in emergence of Nanobiotechnology [3]. Some 
of the nanobiotechnology applications include (a) nanos-
copy for bio imaging [4–7]; (b) nanoparticle for subcel-
lular fractionation [8]; (c) nanoparticle for drug delivery, 
vaccine [9]; (d) nanoparticle for cancer therapy by hyper-
thermia [10]; (e) nanomaterials for tissue engineering and 
artificial/synthetic organ generation [11]; (f ) nanotech-
nology for cell tracking [12, 13]; and (g) nanotechnology 
for large-scale data generation [14]. Particularly, use of 
nanotechnology in generating subcellular omics is less 
studied and understood. This article focuses on nanobio-
technology strategy for organelle isolation and also deci-
phers innovative approaches for omics analysis. Using 
physical properties, its nanoparticle-cell interaction and 
endocytosis machinery, we propose the nanobiotech-
nology strategy that has robust advantages in isolating 
subcellular compartments [15]. Due to such advantages, 
it is possible to isolate subcellular compartments in 
native and physiological conditions. In this article, we 
also case study the impact of nano-biotechnology tool for 
subcellular omics analysis.
2  Subcellular omics
To generate subcellular omics datasets, it is essential to 
understand the locality and functional activity of pro-
teins in given eukaryotic cell [16]. It is well-known that 
proteins are spatially distributed and localized function 
[17]. It has been reported that majority of the mature 
glycosylated protein (for example: Nicastrin) are present 
in post-Golgi compartments like plasma membrane, 
endosomes or lysosome and immature glycosylated pro-
tein are present in the pre-Golgi compartments [18]. 
Similarly, cholesterol is predominately present in the cell 
membrane at the level of 90  % of the total cholesterol 
level in cell extract [19]. While performing proteom-
ics or lipidomics in total cell extract or single cell omics, 
there is a high possibility of reduced spatial and localized 
distribution of proteins and lipids in any given cell. This 
has led to a major interest for subcellular omics such as 
plasma membrane and endosomal compartments like 
endosomes and lysosomes [20]. This is due to several 
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scientific findings which confirm that the majority of pro-
tein functional activity and substrate cleavage occurs at 
cell surface and endosomal compartments (Table 1) [21]. 
Similarly by isolating plasma membrane or endosomes, 
it is possible to generate proteomics, glycomics and lipi-
domics for these organelles [22]. By compiling obtained 
omics (proteomics, glycomics, and lipidomics), for dif-
ferent organelles, comprehensive whole cell omics can 
be generated both under native and altered conditions 
[23–26]. The key factor for generating comprehensive 
omics datasets s is to isolate subcellular compartments 
with high purity and yield. Several types of fractionation 
methodologies have been applied for organelle isolation 
for subcellular omics analysis. In the technology review, 
we elaborate advantages among different subcellular 
compartmental isolation and how nanobiotechnology 
strategy is superior in isolating plasma membrane and 
endosomes as in Tables 2 and 3.
3  Technology review
3.1  Organelle fractionation and subcellular 
compartmental isolation
The governing factor for organelle fractionation is 
high yield and high purity (Fig.  1). Most commonly 
used methodology is density-gradient centrifugation 
(sucrose-based fractionation). This method is based on 
principle of differential (density) equilibrium or non-
equilibrium based centrifugation for organelle separa-
tion [27, 28]. Other commonly used fractionation is 
antibody based pulldown assay. This assay makes use of 
magnetic beads that are tagged with antibodies selec-
tively targeting the subcellular compartments [29]. An 
example is the use of TOM22 antibodies conjugated 
with magnetic beads for mitochondria isolation [30, 31]. 
This principle is also used for post-nanoparticle labeling 
based fractionation. Here, organelle-specific antibody 
conjugated nanoparticles are used to target fractionated 
Table 1 List of subcellular organelles and their functions
Subcellular Organelles Isolation techniques
Cell wall Gradient centrifugation
Chloroplast Gradient centrifugation antibody based pull-down assay, SPMNPS: Tag-anti-tag; Antibody conjugated; Biotin-streptavidin
Cilia and flagella Gradient centrifugation Antibody based pull-down assay; Tag-anti-tag; Antibody conjugated; Biotin-streptavidin
Cytoplasm Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged 
SPMNPs
Cytoskeleton Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin SPM-
NPs
Early endosomes Gradient centrifugation SPMNP isolation assay antibody based pull-down assay; Biotin-streptavidin tagged SPMNPs; 
antibody-SPMNPs; Negatively charged lipid-SPMNPs
Endoplasmic reticulum 
(ER)—rough or smooth
Gradient centrifugation antibody based pull-down assay; Tag-anti-tag; Antibody conjugated; Biotin-streptavidin tagged 
SPMNPs
Golgi apparatus Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged 
SPMNPs
Late endosomes Gradient centrifugation SPMNP isolation assay; Biotin-streptavidin; antibody-SPMNPs; Negatively charged SPMNPs
Multi-vesicular bodies Gradient centrifugation SPMNP isolation assay; antibody based pull-down assay; Biotin-streptavidin; antibody-SPMNPs
Nucleus Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin
Peroxisomes Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged 
SPMNPs
Phagosomes Gradient centrifugation SPMNP isolation assay Antibody based pull-down assay; Biotin-streptavidin; antibody SPMNPs
Lysosomes Gradient centrifugation SPMNP isolation assay Antibody based pull-down assay; Biotin-streptavidin tagged SPMNPs; 
antibody
Plasma Membrane or Cell 
Membrane
Gradient centrifugation; Cationic silica beads; SPMNP isolation; antibody conjugated; Biotin-Streptavidin; lectin–SPMNPs
Ribosomes Gradient centrifugation; pull -down assay; anti-S10/anti–EF-Tu-SPMNPs; Biotin-streptavidin; antibody- SPMNPs
Lipid rafts Gradient centrifugation antibody based pull-down assay; Tag-antitagged-SPMNPs; Biotin-streptavidin; protein conjugated 
magnetic isolation
Secretory granules or 
vesicles
Gradient centrifugation antibody based pull-down assay; Tag-antitagged SPMNPs; Biotin-streptavidin-SPMNPs
Synaptosomes Gradient centrifugation antibody based pull-down assay; Tag-anti-tag SPMNPs; Antibody conjugated; Biotin-streptavidin 
SPMNPs
Vacuoles Gradient centrifugation; antibody based pull-down assay; antibody conjugated magnetic nanoparticles
Mitochondria Gradient centrifugation; pull-down assay; antibody conjugated SPMNPs; Tag-anti-tagged; Antibody conjugated; Biotin-
streptavidin; Anti-TOM22 antibody tagged SPMNPs
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subcellular compartment. This technique is largely used 
in isolating compartments that are larger in size and 
less dynamic or more static such as ER, Golgi, nucleus, 
mitochondria and lysosomes [32]. However, the applica-
bility of this technique is limited as it cannot be used to 
isolate intact cell membrane. Many methods have used 
Table 2 Comparison of existing technologies for plasma membrane isolation
Isolation methodologies Advantages Disadvantages
Density Gradient Centrifugation Conventional method that can be used to isolate plasma mem-
brane along with other subcellular compartments
 Effective method to isolate lysosomes from tissue or in vivo cell 
fractions
Simple procedure that can be performed using an ultracentri-
fuge
 Low yield and low purity
 Cannot isolate intact membrane layers
Not efficient for isolating cell membrane lipids 
and for performing functional studies
Cationic silica based isolation Classical method used to isolate cell membrane layers with high 
purity
Generic method used to isolate cell membrane from tissue, 
in vitro and in vivo
Formation of matrix by the use of polylysine crosslinker helps in 
the isolation of membrane layers without any breakage
 Low yield
 Isolates only available membrane layer i:e only 
50 % of cell surface of adherent cells grown on 
a petri dish
 Not robust to perform lipidomics, glycomics and 
native condition experiments
Cell Surface biotinylation based 
pull-down assay
Generic method that targets cell surface lysine residue
Can be used in combination with magnetic or non-magnetic 
beads
Can be used in combination to isolate endosomal compart-
ments
Can isolate only available membrane layer i:e only 
50 % of cell surface of adherent cells growing 
on a petri dish
Technology has not been established to isolate 
cell membrane from cell suspension
Requires detergent in fractionations
Antibody conjugated magnetic 
nanoparticle based pulldown 
assay
Can be used to pull down proteins after post-fractionation
Can also be used to target selective micro-domains
 Can be used in combination with biotin-streptavidin assay
 Isolates only available membrane layer (only 50 % 
surface of adherent cells on a petri dish
Technology has not been established to isolate 
cell membrane from cell suspension
requires detergent in fractionations
SPMNPs based plasma mem-
brane isolation;
A novel strategy that is generic for any kind of cell systems
 Method does not involve use of detergent or antibody that 
affects the nativity of membranes
 Method can also use targeted plasma membrane micro-domain 
by using ligand-tagging
Can be used to isolate protein under native conditions which 
can hence be used for functional studies
Can isolate cell membrane lipids
Can perform, first of its kind, cell membrane glycosylation
High yield and high purity
 Can be used in combination with endosomal isolations
 Technology has not be established for tissue cell 
membrane isolation and in vivo experiments
Isolates only available membrane layer (only 50 % 
surface of adherent cells on a petri dish
Technology has not been established to isolate 
cell membrane from cell suspension. Possibility 
exists to use this technology for cells in suspen-
sion culture






Conventional method that can be used to isolate endosomes and lys-
osomes along other subcellular compartments
 Effective method to isolate lysosomes from tissue or in vivo cell fractions
 Simple procedure that can be performed using an ultracentrifuge
 Low yield
Difficulties in separating endosomes from lysosome 
vesicles




Can be used to pull down proteins after post-fractionation
Can also be used to target selective endocytic uptakes
Can be used in combination with biotin-streptavidin assay
 Limited applicability for certain endocytosis uptake
 Limited yield and low purity
 Cannot isolate vesicles under native conditions
SPMNPs based 
isolation;
A novel strategy that is generic for any kind of cell systems with reason-
able purity and yield
 Method does not involve the use of detergent or antibody that affects 
native conditions
Method can also use targeted endosomal uptake pathway by using 
ligand tagged nanoparticle
 Can be used to isolate protein under native conditions and all endoso-
mal uptake
Technology has not be established for isolation of 
vesicles form tissue cells and in vivo experiments
 Technology has not been established to isolate vesi-
cles from cell suspension. Possibility exists to use this 
technology for cells in suspension culture
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charge based affinity to isolate eukaryotic cell mem-
brane [33]. The cell membrane is negatively charged due 
to presence of anionic components such as proteins, 
lipids and carbohydrates. Hence, conventional method 
such as cationic latex or silica beads is used for isolat-
ing cell membrane. By using poly-lysine for crosslinking 
silica beads, cell membranes are isolated as cross-linked 
membrane layers which are disadvantage for performing 
functional studies [34]. An alternative method that has 
been used is biotin-streptavidin affinity fractionation. 
The main principle behind biotin-streptavidin affin-
ity assay is based on selective binding of available lysine 
residues on cell surface protein by biotin molecule which 
is further captured by streptavidin [35]. These streptavi-
din tagged micro beads or magnetic beads are used to 
pull down cell membrane protein or protein complexes 
from cell fractionation. By using pulse-chase method 
(elaborated in the later part of the paper), biotin-strepta-
vidin affinity can be used to isolate early, intermediate 
and late endosomal compartments [36]. Recently, nano-
particle based fractionation has emerged as the strategy 
to isolate dynamic subcellular compartments like cell 
membrane, endosomes and lysosome by using endocy-
tosis machinery.
Fig. 1 Subcellular compartments and specific purification methodology
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There are different categories of endocytosis (Fig.  2). 
One of the main subsets is phagocytosis that mainly 
involves cellular uptake of beads of size 1–100 microns 
using phagosome [37, 38]. Another strategy is use of 
pinocytosis which is further classified into (1) micro-
pinocytosis (<1 micron) [39]; (2) clathrin-mediated 
pinocytosis: size ~120  nm by clathrin mediated recep-
tor-ligand induced cellular uptake [40]; (3) caveolin-
mediated pinocytosis: is cellular uptake that uses 
caveolin and lipid rafts in endosomal assembly with 
size of 20–60  nm [41]; and (4) caveolin and clathrin 
independent endocytosis (<90  nm) that is independ-
ent of clathrin and caveolin but includes ARF6 [42]. In 
macropinocytosis, there is non-specific cellular uptake, 
which is mainly utilized by several nanoparticles–cell 
interactions [43]. In clathrin mediated endocytosis, 
ligand coupled nanoparticle endocytosis through recep-
tor mediated uptake mechanism [44, 45]. While for 
caveolin mediated endocytosis, targeting caveolin1/2 or 
lipid raft associated protein flotilin-1 with the specific 
antibody tagged nanoparticle is the commonly used 
approach [46]. However, when clathrin mediated endo-
cytosis was blocked using sucrose, nanoparticle uptake 
was not limited, and thereby showing that there is size 
dependent cellular uptake of nanoparticle via caveo-
lin mediated endocytosis [47]. Nevertheless it is clear 
that surface coating and size of the nanoparticle are 
governing factors for selective endocytosis and cellular 
uptake.
4  Nanoparticle synthesis
The surface functionalization, size, physical properties 
and endocytosis machinery of nanoparticle are key fac-
tors for nanobiotechnology strategy. The physical proper-
ties are dependent on the type of core–shell material [48, 
49]. It is possible to govern the magnetic properties of the 
nanoparticle by using iron oxide or cobalt-iron oxide as a 
core. Here superparamagnetic properties can be achieved 
when nanomaterial is of size <30 nm [50]. Shell material 
(surface coating) which acts as an interface between core 
and biological environment governs the use of nanopar-
ticle for different biological applications. Nanoparticles 
that are synthesized in organic phase tend to be water 
insoluble. They require an additional step of exchange 
with water soluble ligands for biological applications. 
Commonly used methods for synthesizing nanoparticle 
are (a) chemical precipitation method and (b) thermal 
decomposition method [51]. Thermal decomposition 
method is preferred for its high monodispersity (in terms 
of its size) and high quality yield. However, it requires 
additional step for water-soluble ligand exchange or addi-
tion [52, 53] (Fig. 3). Further, functionalized nanoparticle 
can be used for ligand coupling and bioconjugation using 
the free end-groups like NH2, COOH and -SH.
Fig. 2 Endocytosis pathway
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5  Bioconjugation strategy for subcellular 
interaction
Surface functionalization of nanoparticle determines the 
kinetics behind nanoparticle-cellular uptake. Depending 
on the surface coating, nanoparticle can be  ±  charged 
which is determined by the presence of NH2 and COOH 
respectively. Addition of PEG group in supports bio-
compatibility [54] and the nanoparticle can be further 
functionalized by coupling with the endgroup (Fig.  4). 
By tagging fluorescent ligand, it is possible to perform 
live cell imaging and nanoparticle tracking for studying 
the receptor-ligand and nanoparticle-cell interaction. 
Depending on the target, an appropriate ligand can be 
selected and conjugated to the nanoparticle [55]. Ligand 
size and shape determines the surface area to volume 
ratio which is the governing factor for nanoparticle func-
tionalization [56]. Another key factor is ligand selection. 
Ligand selection depends—(a) receptor that can be well 
internalized (for cellular trafficking); b) 1:1 ratio of ligand: 
nanoparticle to avoid nanoparticle crosslinking. Here we 
illustrate three strategies for bioconjugation of SPMNPs 
that are functionalized with lipids, DMSA, TMAOH 
(Fig.  5). First approach is to use monovalent avidin and 
target biotinylated protein. Second approach proposes 
the conjugation of FIAsH-EDT2 with SPMNPs. FIAsH-
EDT2 coupled SPMNPs are used to couple tetra-cysteine 
containing motif proteins [57]. Third approach is to con-
jugate SPMNPs with DOGS-NTA-Ni (II) in order to 
anchor histidine-tagged protein. However, major limita-
tion for bioconjugation is nanoparticle aggregation due 
to coupling reagent like glutaraldehyde. Although glu-
taraldehyde works very well for protein conjugation and 
crosslinking, there are tendency for reagent to result in 
multiple layer crosslinking among nanoparticles due to 
non-specific interaction and competitive affinity. Such 
multilayer crosslinking results in increase of size and 
change in physical properties, thereby affecting organelle 
isolation. Hence some key guidelines to be considered 
during bioconjugation of nanoparticles are (1) retain-
ing size and stability of nanoparticle; (2) performing 
sequential bioconjugation; (3) implementing biocompat-
ible surface functionalization; and (4) finally, a strategy 
that monitors protein association/disassociation with the 
nanoparticle. 
6  Pulse‑chase methodology
Pulse-chase methodology is a commonly used approach 
to study the mechanism of endocytosis. Generally, pulse-
chase strategy for omics analysis includes five stages or 
phases wherein Phase-I: includes generation of water-
soluble nanoparticle by existing (thermal decomposi-
tion or chemical precipitation) synthesis and quality 
control using characterization; Phase II: includes selec-
tive bioconjugation of nanoparticle for a selective path-
way-specific cellular uptake. For such pathway-specific 
cellular uptake, protein/ligand/synthetic peptide is used 
for receptor mediated endocytosis and charge depend-
ent shell uptake is used for receptor independent endo-
cytosis. Phase III: Pulse-Chase methodology is used to 
optimize pulse and chase period to selectively localize 
nanoparticle in vesicle. Phase IV: Magnetic separation 
strategy is used for subcellular compartmental enrich-
ment along with ultracentrifugation. Phase V: Endo-
somal proteome using Mass Spectrometry analysis. 
Fig. 3 Manufacturing of water-soluble superparamagnetic nanopar-
ticles
Fig. 4 Nanoparticle-cell interaction
Page 7 of 12Thimiri Govinda Raj and Khan  Nano Convergence  (2016) 3:22 
This pulse-chase strategy was commonly used in radio-
active labeling in the cell and this technique has now 
been extended to nanoparticle based subcellular com-
partmental isolation (Fig.  6). Briefly, pulse-chase strat-
egy is used to govern receptor-mediated endocytosis 
of nanoparticle-ligand complex and has recently been 
extended to other endocytosis mechanisms [58]. Dur-
ing pulse period, nanoparticle is incubated with cells at 
37  °C or at 4  °C for a certain period of time (0–1 h.) in 
the presence of medium. Depending on the application, 
nanoparticle with appropriate concentration is incu-
bated in PBS or culture medium at 4  °C (for non-chase 
conditions) and 37  °C (for chase conditions). This time 
frame allows nanoparticle to interact with the cell sur-
face and its protein. Depending on the dynamics and 
kinetics of nanoparticle-ligand interaction, pulse incuba-
tion involves a time period in the range of 10 min to 1 h. 
For example, if it is for cell membrane or plasma mem-
brane isolation, the nanoparticle is incubated at 4 °C for 
15–20 min in PBS with the adherent cells. Depending on 
whether the cells are adherent or in suspension, or it is 
receptor mediated or charge mediated, there is variation 
in the pulse time period required for cellular uptake [59]. 
After pulse period is performed, the chase is incubated at 
appropriate time period depending on the compartmen-
tal isolation. Chase period represents the time where the 
nanoparticle containing medium is replaced with fresh 
medium without nanoparticle. This supports stream-
lining nanoparticle internalization in the cell and accu-
mulation of nanoparticle into a certain compartment 
of interest depending on the timeframe. For endosomal 
isolation, chase period is generally for a timeframe of 
10–15 min. For late endosomes, chase period is generally 
for 15–20 min and for lysosomes it is more than 30 min. 
However since endocytosis is dynamic in mechanism, it 
is relatively difficult to isolate highly pure early and late 
endosomes (Fig. 7). At the same time it is possible to iso-
late highly pure lysosome by performing a chase period 
of more than 3 h and up to 24 h. This is mainly because 
lysosome is the endpoint for most of the endocytosis 
[60]. For targeting, phagosome or autophagosome, chase 
period is adjusted accordingly for 30–60  min before 
phagosome fuses to lysosome. Nanoparticle can be con-
centrated in lysosome after 60  min of chase period. An 
advantage of using chase period is that it provides use-
ful information for nanoparticle tracking. For this reason, 
fluorescence tagged nanoparticle is used for pulse–chase 
methodology and live-cell imaging [61]. By incubating 
Fig. 5 Bioconjugation strategy for nanoparticle
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with endocytic inhibitors for endosomal or lysosomal 
fusion, it is possible to limit the nanoparticle-cellular 
internalization and subcellular trafficking. For example, 
by limiting the endosome-lysosomal fusion using Latrun-
culin-A, it is possible to concentrate the nanoparticle in 
early or late endosomes [62]. It is also reported that the 
Fig. 6 Step by step approach toward subcellular compartmental proteomics
Fig. 7 Pulse-chase methodology
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nanoparticle coupled ligand does not mimic the ligand 
cellular uptake and subcellular compartment localization. 
Few examples in the later part of this article elaborate 
on the deviation in cellular uptake. These examples are 
confirmed by using pulse-chase methodology, magnetic 
organelle isolation and live cell imaging using fluores-
cence tag [63]. For optimal use of pulse-chase method, it 
is important to establish a methodology for specific sub-
cellular compartments. Here, we describe two interest-
ing nanoparticle based methodologies to isolate plasma 
membrane and endosomal compartments using affinity 
purification.
7  Nanoparticle based novel method for plasma 
membrane affinity purification
Figure  8 represents the step-by-step strategy to isolate 
plasma membrane using nanoparticle based affinity puri-
fication. Briefly, SPMNPs coated with positively charged 
NH2 functionalized PEGylated lipids are incubated with 
adherent cells grown in a 10 cm dish or a 75 cm2 flasks. 
The time period of incubation is generally 15 to 20 min 
at 4 °C in PBS with horizontal shaking such that it doesn’t 
detach the cells. (Note: An additional step of incubating 
adherent cells at 4 °C for 30 min before nanoparticle-cell 
interaction is recommended). After incubation, the nan-
oparticle containing supernatant is removed and washed 
twice with fresh ice-cold PBS. Cells are removed from 
the dish/flask by scrapping the cells. Detachment of cells 
using trypsin is not recommended as it might affect cell 
surface proteins which this method aims to isolate. Cell 
suspension is further homogenized using a homogenizing 
apparatus and buffers that maintain physiological condi-
tions. Further, nuclear fraction and unbroken cells are 
separated from post nuclear fraction by centrifuging at 
800 rpm for 10 min at 4 °C. The post nuclear fraction is 
passed through the magnetic field. Here, the unbound 
fraction is eluted while the magnetic fraction is further 
washed with 1 M potassium chloride and 0.1 M sodium 
carbonate solution in the presence of magnetic field. An 
additional washing step with homogenizing buffer can be 
included to further clear the unbound material. 1 M KCl 
and 0.1 M Na2CO3 solution are used to remove cytoskel-
eton-associated compartments from the cell surface pro-
teins. Further, the magnetic field is removed and bound 
fraction is eluted from the column. Finally the bound 
fraction is enriched by pelleting at 50,000  rpm for 1  h. 
The pellet is resuspended in an appropriate amount of 
PBS for further analysis like mass spectrometry.
8  Nanoparticle based novel method 
for endosomes and lysosomal affinity 
purification
Figure 9 represents another step-by-step strategy to iso-
late endosomes and lysosomes using nanoparticle based 
affinity purification. Briefly, DMSA or TMAOH or Silane 
coated nanoparticles are incubated with adherent cells 
that are grown in 10  cm dishes. The pulse time period 
is generally 15 to 20 min at 37 °C in medium with hori-
zontal shaking such that it doesn’t detach the cells. After 
incubation, the SPMNPs containing medium is removed, 
washed twice with fresh medium and incubated for the 
chase period (0–24 h) with fresh medium. Cells are then 
Fig. 8 Strategy towards Plasma Membrane isolation
Page 10 of 12Thimiri Govinda Raj and Khan  Nano Convergence  (2016) 3:22 
removed from the dish/flask by scraping. Cell suspen-
sion is further homogenized as explained in the previous 
section. Further, nuclear fraction and unbroken cells are 
pelleted at 800 rpm for 10 min at 4 °C. The post nuclear 
fraction is passed on the column in presence of magnetic 
field. Here, unbound fraction is eluted while the magnetic 
fraction is further washed with the homogenizing buffer 
to further clear unbound material. This is followed by 
the removal of magnetic field and elution of the bound 
fraction from the column. Finally the bound fraction is 
enriched by pelleting at 50,000 rpm for 1 h. The pellet is 
resuspended in PBS for further analysis. Based on chase, 
the subcellular localization of nanoparticles can be deter-
mined as illustrated Early (~10 min), Late (~20 min) and 
Lysosomes (>30 min) [57, 58, 64–68].
Although nanoparticle-protein complex can be used 
for endosomal trafficking and for proteomics, there 
are illustrations, which show that nanoparticle-pro-
tein complexes are trafficked differently compared 
to the target protein complex. For example, traffick-
ing of ricin conjugated nanoparticle is reported to be 
unlike the ricin ligand where trafficking occurs from 
early endosomes (EE), trans-Golgi network (TGN) and 
finally to endoplasmic reticulum (ER). It is well known 
that transferrin is recycled to the cell surface via recy-
cling endosomal compartments such as recycling endo-
some via early endosomes and multi-vesicular bodies. 
However, transferrin conjugated nanoparticle and Shiga 
toxin (ricin) conjugated nanoparticle are shown to traf-
fic from early endosomes to late endosomes and finally 
accumulated at lysosomes. It is also reported the Shiga 
toxin conjugated nanoparticle tend to accumulate at early 
endosomes while Shiga toxin traffic like ricin (from EE to 
TGN and finally to ER).
9  Conclusion
Tables  2 and 3 list the commonly used techniques for 
subcellular isolation of plasma membrane and lys-
osomes with high purity and yield. Both tables show 
that nanoparticle based methods hold many advantages 
as compared to existing methods. Using the isolation 
technology, several omics datasets for subcellular com-
partments can be generated for any given cell. There is 
an interesting aspect in the use of nanoparticle based 
method that is generic in nature. Hence, the method can 
be applied to wild-type and diseased cell-type (for exam-
ple cancer cell) for plasma membrane and endosomal 
compartmental isolation. By using the nanoparticle based 
subcellular compartmental isolation; one could poten-
tially generate a complete and comprehensive plasma 
membrane or endosome or lysosome proteomics, gly-
comics and lipidomics for any cell type. By the generated 
subcellular omics, nanobiotechnology can serve as a use-
ful tool to build omics datasets for cancer biology using 
Fig. 9 Strategy towards endosomal isolation
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the bottom-up pyramid approach. Using the bottom-up 
pyramid approach in omics analysis, subcellular omics 
datasets (including genomics, proteomics, lipidomics and 
glycomics) can be compiled together and compared with 
the whole cell omics analysis. This approach can also be 
used to generate several omics datasets in cancer biology 
that can enable the researchers to revisit the subcellular 
omics in order to understand the biological significance 
and functional relevance. For all such omics analysis stud-
ies, it is necessary to have an efficient, robust and high 
precision technology for subcellular compartmental iso-
lation. The technology also needs optimization and fine 
tuning depending on its applicability with host cell sys-
tem. Using different nanobiotechnology tools for subcel-
lular compartmental isolation, several high-throughput 
functional omics dataset like fluxomics, metabolomics, 
interactomics and localizomics can be generated. Using 
all these datasets, comprehensive Phenome and subcellu-
lar omics are generated that can by analyzed using nano-
technology for data storage studies. Further dataset thus 
gets larger for different diseases such as cancer, diabetes, 
infectious diseases, ageing related diseases, and neurode-
generative diseases. These dataset and nanotechnology 
based analytics can be used in drug development, pre-
clinical studies, patent analytics, and other applications. 
As a future perspective, the use of nanoparticle as nano-
biotechnology tool is all set to be a game changer in the 
generation of Datasets for systems biology.
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